Laboratory News and Research

RSS

Glyphosine can prevent development of type 1 diabetes

Researchers at the University of Colorado School of Medicine have found a specific molecule that can prevent the development of type 1 diabetes in mice and has a similar effect on human cells from diabetic patients.

2 Nov 2011

MIT develops new software to speed up MRI scans

Magnetic resonance imaging (MRI) devices can scan the inside of the body in intricate detail, allowing clinicians to spot even the earliest signs of cancer or other abnormalities. But they can be a long and uncomfortable experience for patients, requiring them to lie still in the machine for up to 45 minutes.

2 Nov 2011

UL, IU and UMMS to implement Center for Excellence in Health and Life Sciences

Indiana University today announced that it is partnering with the University of Liberia and the University of Massachusetts Medical School to administer a transformative $7.2 million project that will address a national shortage of healthcare workers in Liberia, an African nation with which IU has had long-standing ties.

1 Nov 2011

Ultra-sensitive techniques for early detection of breast cancer

A team of scientists at Tufts University will develop ultra-sensitive techniques at the single-molecule and single-cell levels designed to detect breast cancer earlier, and treat it with greater precision, through a $6.6 million Innovator Award from the Department of Defense Breast Cancer Research Program made to Tufts chemist David R. Walt, Ph.D.

1 Nov 2011

Study: People with schizophrenia have weakened sense of body ownership

A study using a procedure called the rubber hand illusion has found striking new evidence that people experiencing schizophrenia have a weakened sense of body ownership and has produced the first case of a spontaneous, out-of-body experience in the laboratory.

1 Nov 2011

Multi-centre phase II trial for new brain tumor surgical technique starts in the UK

A multi-centre phase II clinical trial for a pioneering new surgical technique has started in the UK, jointly funded by Samantha Dickson Brain Tumour Trust and Cancer Research UK.

1 Nov 2011

Research into new Alzheimer's medication

Several potential drugs for the treatment of Alzheimer's have worked well on mice - but none of them on humans. A leading researcher from the Sahlgrenska Academy at the University of Gothenburg, Sweden, is now launching brand new methods for diagnosing Alzheimer's and monitoring treatment.

1 Nov 2011

Gender not an independent predictor of mortality post-PCI

New research shows that women undergoing percutaneous coronary intervention (PCI), also known as angioplasty, exhibit more co-morbidities and cardiovascular risk factors than men. Risk-adjusted analyses have now indicated that, in the contemporary era, gender is not an independent mortality predictor following PCI according to the study now available in Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions.

1 Nov 2011

Psyche Systems and Aperio partner to provide integrated LIS and Digital Pathology solution

Psyche Systems Corporation and Aperio announced today that the companies have formed a strategic relationship which will provide customers an end-to-end integrated LIS and Digital Pathology solution.

31 Oct 2011

FDA grants Premarket Approval for Roche's IgM antibody to hepatitis B core antigen assay

Roche announced today that the U.S. Food and Drug Administration granted Premarket Approval for its IgM antibody to hepatitis B core antigen (Anti-HBc IgM) assay for use on the cobas e 601 analyzer, the immunoassay module of the cobas 6000 analyzer series for mid-volume laboratories.

From Roche Sequencing and Life Science 31 Oct 2011

Gen-Probe receives FDA approval for APTIMA HPV assay

Gen-Probe Incorporated announced today that the US Food and Drug Administration (FDA) has approved its APTIMA HPV assay, an amplified nucleic acid test that detects high-risk strains of human papillomavirus (HPV) that are associated with cervical cancer and precancerous lesions.

31 Oct 2011

COPCP chooses eClinicalWorks comprehensive EHR solution

eClinicalWorks, a market leader in ambulatory clinical systems, today announced that Central Ohio Primary Care Physicians (COPCP), the second largest privately-owned primary care group in the United States, has chosen eClinicalWorks comprehensive electronic health records (EHR) solution for its 230 physicians across 44 practices.

31 Oct 2011

Asuragen introduces ARQ IS Calibrator Panels to improve BCR-ABL1 testing for CML

Asuragen, Inc. announced today that it has commercially launched the ARQ IS Calibrator Panels (RUO), intended to aid laboratories with standardization of BCR-ABL1 quantitative measurements on the International Scale.

31 Oct 2011

Scientists discover how toxic form of htt protein causes Huntington's symptoms

Scientists at the Gladstone Institutes have discovered how a form of the protein linked to Huntington's disease influences the timing and severity of its symptoms, offering new avenues for treating not only this disease, but also a variety of similar conditions.

31 Oct 2011

Thyroid researcher to receive ATA's John B. Stanbury Pathophysiology Medal

Each year, the American Thyroid Association (ATA) recognizes the outstanding research contributions of one of its members to a greater understanding of thyroid physiology or the pathophysiology of thyroid disease, with its presentation of the John B. Stanbury Pathophysiology Medal at its Annual Meeting.

29 Oct 2011

First rapid measurements of dopamine release in human brain

A research team led by investigators at the Virginia Tech Carilion Research Institute has demonstrated the first rapid measurements of dopamine release in a human brain and provided preliminary evidence that the neurotransmitter can be tracked in its movement between brain cells while a subject expresses decision-making behavior.

29 Oct 2011

Research focuses on JQ1 molecule that tricks NUT midline carcinoma cancer cells

NUT midline carcinoma (NMC) is a cancer without a cure, and one that affects all age groups. NMC is a rapid-growth disease with an average survival time of four and a half months after diagnosis, making the development of clinical trials for potential therapies or cures for this cancer difficult, to say the least.

29 Oct 2011

ZIOPHARM reports promising preclinical data with palifosfamide in pediatric sarcoma model

ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, today announced the presentation of promising preclinical data with palifosfamide in a pediatric sarcoma model.

29 Oct 2011

Researchers identify compound that inhibits viral replication

Broad-spectrum antibiotics, which are active against a whole range of bacterial pathogens, have been on the market for a long time. Comparably versatile drugs to treat viral diseases, on the other hand, have remained elusive. Using a new approach, research teams led by Dr. Albrecht von Brunn of LMU Munich and Professor Christian Drosten from the University of Bonn have identified a compound that inhibits the replication of several different viruses, including the highly aggressive SARS virus that is responsible for severe acute respiratory syndrome.

29 Oct 2011

Number of polio cases in Pakistan exceeds total number reported in three other endemic countries, report says

According to a report published earlier this month in Virology Journal by a team at the bioinformatics laboratory of the Centre for Excellence in Molecular Biology (CEMB) in Lahore, Pakistan, that country is reporting more polio cases than Nigeria, India and Afghanistan -- the three other countries where the disease is endemic -- combined, SciDev.Net reports.

29 Oct 2011